¡Atención! Este sitio usa cookies y tecnologías similares.

Si no cambia la configuración de su navegador, usted acepta su uso. Saber más

Acepto

Bibliografía

Bibliografía vitamina del grupo B

 
  • (1998). "Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration." BMJ 316(7135): 894-898.
  • (2001). PDR for Nutritional Supplements. Montvale.
  • (2005). "Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials." Am J Clin Nutr 82(4): 806-812.
  • Almawi, W. Y., R. R. Finan, et al. (2004). "Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population." Am J Hematol 76(1): 85-87.
  • Anonymousb3 (1998). Chapter 6 - Niacin. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. I. o. M. National Academy of Sciences, Food and Nutrition Board. Washington, D.C., National Academy Press: 150-195.
  • Anonymousb6 (1998). Chapter 7 - Vitamin B6. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. I. o. M. National Academy of Sciences, Food and Nutrition Board. Washington, D.C., National Academy Press: 58-86.
  • Anonymousb9 (1998). Chapter 8 - Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. I. o. M. National Academy of Sciences, Food and Nutrition Board. Washington, D.C., National Academy Press: 58-86.
  • Apeland, T., M. A. Mansoor, et al. (2001). "Antiepileptic drugs as independent predictors of plasma total homocysteine levels." Epilepsy Res 47(1-2): 27-35.
  • Baik, H. W. and R. M. Russell (1999). "Vitamin B12 deficiency in the elderly." Annu Rev Nutr 19: 357-377.
  • Bailey, L. B. and J. F. Gregory, 3rd (1999). "Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement." J Nutr 129(5): 919-922.
  • Bartoszyk, G. D. (1990). "[The interactions of vitamins B1, B6 and B12 with non-steroidal antirheumatic and analgesic drugs: animal experiment results]." Klin Wochenschr 68(2): 121-124.
  • Bartoszyk, G. D. and A. Wild (1989). "B-vitamins potentiate the antinociceptive effect of diclofenac in carrageenin-induced hyperalgesia in the rat tail pressure test." Neurosci Lett 101(1): 95-100.
  • Baynes, J. W. and S. R. Thorpe (2000). "Glycoxidation and lipoxidation in atherogenesis." Free Radic Biol Med 28(12): 1708-1716.
  • Bazzano, L. A., K. Reynolds, et al. (2006). "Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials." JAMA 296(22): 2720-2726.
  • Bender, D. A. (1999). "Non-nutritional uses of vitamin B6." Br J Nutr 81(1): 7-20.
  • Bohles, H. (1997). "Antioxidative vitamins in prematurely and maturely born infants." Int J Vitam Nutr Res 67(5): 321-328.
  • Boushey, C. J., S. A. Beresford, et al. (1995). "A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes." JAMA 274(13): 1049-1057.
  • Brody, T. (1999). Nutritional Biochemistry. San Diego, Academic Press.
  • Butterworth, R. F. (2006). Thiamin. Modern Nutrition in Health and Disease. M. E. Shils, M. Shike, A. C. Ross, B. Caballero and R. J. Cousins. Baltimore, Lippincott Williams & Wilkins.
  • Camporeale, G. and J. Zempleni (2006). Biotin. Present Knowledge in Nutrition. B. A. Bowman and R. M. Russell. Washington, D.C., ILSI Press. 1: 314-326.
  • Carol P. Wilson, Helene McNulty, Mary Ward, J.J. Strain, Tom G. et al.-Blood Pressure in Treated Hypertensive Individuals With the MTHFR 677TT Genotype Is Responsive to Intervention With Riboflavin: Findings of a Targeted Randomized Trial.Hypertension, 2013;61:00-00

  • Clarke, R., S. Lewington, et al. (2007). "Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia." Curr Opin Clin Nutr Metab Care 10(1): 32-39.
  • Coronel, F., F. Tornero, et al. (1991). "Treatment of hyperlipemia in diabetic patients on dialysis with a physiological substance." Am J Nephrol 11(1): 32-36.
  • Council, N. R. (1989). RDAs. Washington, DC, National Academy Press: 132-137.
  • Cui Renzhe, Iso Hiroyasu, Date Chigusa, Kikuchi Shogo, Tamakoshi Akiko. (2010). Dietary folate and Vitamin B6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study. Stroke; a journal of cerebral circulation 2010; 41(6):1285-9.
  • Debourdeau, P. M., S. Djezzar, et al. (2001). "Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H." Ann Pharmacother 35(4): 424-426.
  • Duggal JK, Singh M, Attri N, Singh PP, et al. Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease. J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):158-66.
  • Farah, A. (2009). "The role of L-methylfolate in depressive disorders." CNS Spectr 14(1 Suppl 2): 2-7.
  • Flodin, N. (1988). Pharmacology of micronutrients. New York, Alan R. Liss, Inc.
  • Folsom, A. R., F. J. Nieto, et al. (1998). "Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study." Circulation 98(3): 204-210.
  • Ford AH., Flicker L., Singh U., Hirani V., Almeida OP. Homocysteine, depression

    and cognitive function in older adults. Journal of Affective Disorders. 2013 Aug 5.

  • Forsyth LM (1999), Preuss HG, MacDowell Al, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91.
  • García-Arias, MT et al.  Hierro, ácido fólico y vitaminas B 12 y la ingesta de la dieta C de una población de ancianos institucionalizados en León, España. Nutr. Hosp. [online]. 2003, vol.18, n.4, pp. 222-225. 2003. ISSN 0212-1611.
  • Gaddi, A., G. C. Descovich, et al. (1984). "Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia." Atherosclerosis 50(1): 73-83.
  • Gerhard, G. T. and P. B. Duell (1999). "Homocysteine and atherosclerosis." Curr Opin Lipidol 10(5): 417-428.
  • Guyton, J. R. and D. M. Capuzzi (1998). "Treatment of hyperlipidemia with combined niacin-statin regimens." Am J Cardiol 82(12A): 82U-84U; discussion 85-86U.
  • Halsted, C. (1990). Intestinal absorption of dietary folates. Folic acid metabolism in health and disease. M. F. Picciano, E. L. R. Stokstad and J. F. Gregory. New York, New York, Wiley-Liss: 23-45.
  • Hansen, C. M., J. E. Leklem, et al. (1996). "Vitamin B-6 status of women with a constant intake of vitamin B-6 changes with three levels of dietary protein." J Nutr 126(7): 1891-1901.
  • Head, K. A. (2006). "Peripheral neuropathy: pathogenic mechanisms and alternative therapies." Altern Med Rev 11(4): 294-329.
  • Herbert, V. (1988). "Vitamin B-12: plant sources, requirements, and assay." Am J Clin Nutr 48(3 Suppl): 852-858.
  • Herbert, V. (1996). Vitamin B-12. Present Knowledge in Nutrition. . E. E. Ziegler and L. J. Filer. Washington D.C., ILSI Press: 191-205.
  • Herbert, V. (1999). Folic acid. Nutrition in Health and Disease. M. Shils, J. A. Olson, M. Shike and A. C. Ross. Baltimore, Williams & Wilkins: 433-446.
  • Highdon, J.-F. (2002). "Folic Acid." Retrieved 05 Mar, 2010, fromhttp://lpi.oregonstate.edu/infocenter/vitamins/fa/.
  • Highdon, J.-N. (2002). "Niacin." Retrieved 05 Mar, 2010, fromhttp://lpi.oregonstate.edu/infocenter/vitamins/niacin/.
  • Highdon, J.-T. (2002). "Thiamin." Retrieved 05 Mar, 2010, fromhttp://lpi.oregonstate.edu/infocenter/vitamins/thiamin/index.html.
  • Holmberg, A., A. Blomstergren, et al. (2005). "The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures." Electrophoresis 26(3): 501-510.
  • Hoyumpa, A. M., Jr. (1980). "Mechanisms of thiamin deficiency in chronic alcoholism." Am J Clin Nutr 33(12): 2750-2761.
  • Johnson, L. E. (2007). Folate. The Merck Manual for Healthcare Professionals, Merck. The Merck Manuals: Online Medical Library.
  • Karakula, H., A. Opolska, et al. (2009). "[Does diet affect our mood? The significance of folic acid and homocysteine]." Pol Merkur Lekarski 26(152): 136-141.
  • Kasper, H. (1999). "Vitamin absorption in the elderly." Int J Vitam Nutr Res 69(3): 169-172.
  • Katia Orvin MD, Nira Koren-Morag PhD, Israel Eli Lev MD, Abid Assali MD, Ran Kornowski MD, Mordechai Shohat MD, Alexander Battler MD and David Hasdai MD. Impact of Homocysteine-Lowering Vitamin Therapy on Long-Term Outcome of Patients With Coronary Artery Disease. The American Journal of Cardiology, Volume 104, Issue 6, 15 September 2009, Pages 745-749
  • Kauwell, G. P., C. E. Wilsky, et al. (2000). "Methylenetetrahydrofolate reductase mutation (677C-->T) negatively influences plasma homocysteine response to marginal folate intake in elderly women." Metabolism 49(11): 1440-1443.
  • Knopp, R. H. (1999). "Drug treatment of lipid disorders." N Engl J Med 341(7): 498-511.
  • Kronenberg, G., M. Colla, et al. (2009). "Folic acid, neurodegenerative and neuropsychiatric disease." Curr Mol Med 9(3): 315-323.
  • Kuhlmann, M. K. and N. W. Levin (2005). "Interaction between nutrition and inflammation in hemodialysis patients." Contrib Nephrol 149: 200-207.
  • Leevy, C. M. (1982). "Thiamin deficiency and alcoholism." Ann N Y Acad Sci 378: 316-326.
  • Lenaz, G., R. Fato, et al. (1994). "An updating of the biochemical function of coenzyme Q in mitochondria." Mol Aspects Med 15 Suppl: s29-36.
  • Lin, P. T., C. H. Cheng, et al. (2006). "Low pyridoxal 5’-phosphate is associated with increased risk of coronary artery disease." Nutrition 22(11-12): 1146-1151.
  • Lowik, M. R., H. van den Berg, et al. (1994). "Interrelationships between riboflavin and vitamin B6 among elderly people (Dutch Nutrition Surveillance System)." Int J Vitam Nutr Res 64(3): 198-203.
  • Madigan, S. M., F. Tracey, et al. (1998). "Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people." Am J Clin Nutr 68(2): 389-395.
  • Majchrzak DSinger IMänner MRust PGenser DWagner KHElmadfa I (2006). B-estado de la vitamina y las concentraciones de homocisteína en los omnívoros de Austria, los vegetarianos y veganos.
  • Malinow, M. R., A. G. Bostom, et al. (1999). "Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association." Circulation 99(1): 178-182.
  • Matsui, E. C. and W. Matsui (2009). "Higher serum folate levels are associated with a lower risk of atopy and wheeze." J Allergy Clin Immunol 123(6): 1253-1259 e1252.
  • McCormick, D. B. (1989). "Two interconnected B vitamins: riboflavin and pyridoxine." Physiol Rev 69(4): 1170-1198.
  • McCormick, D. B. (1999). Riboflavin. Modern Nutrition in Health and Disease. M. Shils, J. A. Olson, M. Shike and A. C. Ross. Baltimore, Williams & Wilkins: 391-399.
  • McKenney, J. (2004). "New perspectives on the use of niacin in the treatment of lipid disorders." Arch Intern Med 164(7): 697-705.
  • McNulty, H., K. Pentieva, et al. (2008). "Homocysteine, B-vitamins and CVD." Proc Nutr Soc 67(2): 232-237.
  • Meydani, S. N., J. D. Ribaya-Mercado, et al. (1991). "Vitamin B-6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elderly adults." Am J Clin Nutr 53(5): 1275-1280.
  • Miller, A. L. (2008). "The methylation, neurotransmitter, and antioxidant connections between folate and depression." Altern Med Rev 13(3): 216-226.
  • Pinto, J., Y. P. Huang, et al. (1987). "Mechanisms underlying the differential effects of ethanol on the bioavailability of riboflavin and flavin adenine dinucleotide." J Clin Invest 79(5): 1343-1348.
  • Pitsavas, S., C. Andreou, et al. (2004). "Pellagra encephalopathy following B-complex vitamin treatment without niacin." Int J Psychiatry Med 34(1): 91-95.
  • Plesofsky-Vig, N. (1999). Pantothenic acid. Modern Nutrition in Health and Disease. M. E. Shils, J. A. Olson, M. Shike and A. C. Ross. Philadelphia, Lippincott Williams & Wilkins: 423-432.
  • Powers, H. J. (1999). "Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine." Proc Nutr Soc 58(2): 435-440.
  • Quinlivan, E. P., J. McPartlin, et al. (2002). "Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease." Lancet 359(9302): 227-228.
  • Reynolds, R. D. and C. L. Natta (1985). "Depressed plasma pyridoxal phosphate concentrations in adult asthmatics." Am J Clin Nutr 41(4): 684-688.
  • Rieck, J., H. Halkin, et al. (1999). "Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers." J Lab Clin Med 134(3): 238-243.
  • Rimm, E. B., W. C. Willett, et al. (1998). "Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women." JAMA 279(5): 359-364.
  • Robinson, K., K. Arheart, et al. (1998). "Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group." Circulation 97(5): 437-443.
  • Said, H. M., A. Sharifian, et al. (1990). "Chronic ethanol feeding and acute ethanol exposure in vitro: effect on intestinal transport of biotin." Am J Clin Nutr 52(6): 1083-1086.
  • Schernhammer, E., B. Wolpin, et al. (2007). "Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts." Cancer Res 67(11): 5553-5560.
  • Schumann, K. (1999). "Interactions between drugs and vitamins at advanced age." Int J Vitam Nutr Res 69(3): 173-178.
  • Shane, B. (2000 ). Folic acid, vitamin B-12, and vitamin B-6. Biochemical and Physiological Aspects of Human Nutrition. M. Stipanuk. Philadelphia, W.B. Saunders Co: 483-518.
  • Shaw, G. M., D. Schaffer, et al. (1995). "Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects." Epidemiology 6(3): 219-226.
  • Shimon, I., S. Almog, et al. (1995). "Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy." Am J Med 98(5): 485-490.
  • Spivak, J. L. and D. L. Jackson (1977). "Pellagra: an analysis of 18 patients and a review of the literature." Johns Hopkins Med J 140(6): 295-309.
  • Stabler, S. P., J. Lindenbaum, et al. (1997). "Vitamin B-12 deficiency in the elderly: current dilemmas." Am J Clin Nutr 66(4): 741-749.
  • Stahl, S. M. (2007). "Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent." CNS Spectr 12(10): 739-744.
  • Stanger, O., B. Fowler, et al. (2009). "Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations." Expert Rev Neurother 9(9): 1393-1412.
  • Termanini, B., F. Gibril, et al. (1998). "Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome." Am J Med 104(5): 422-430.
  • Thornalley, P. J. (2005). "The potential role of thiamine (vitamin B1) in diabetic complications." Curr Diabetes Rev 1(3): 287-298.
  • Van Dam, F. and W. A. Van Gool (2009). "Hyperhomocysteinemia and Alzheimer’s disease: A systematic review." Arch Gerontol Geriatr 48(3): 425-430.
  • Villalba, J. M. and P. Navas (2000). "Plasma membrane redox system in the control of stress-induced apoptosis." Antioxid Redox Signal 2(2): 213-230.
  • Voutilainen, S., T. H. Rissanen, et al. (2001). "Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study." Circulation 103(22): 2674-2680.
  • Voziyan, P. A. and B. G. Hudson (2005). "Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage." Cell Mol Life Sci 62(15): 1671-1681.
  • Williams, M. E. (2006). "New potential agents in treating diabetic kidney disease: the fourth act." Drugs 66(18): 2287-2298.
  • Wink, J., G. Giacoppe, et al. (2002). "Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy." Am Heart J 143(3): 514-518.
  • Winkler, C., B. Wirleitner, et al. (2006). "Beer down-regulates activated peripheral blood mononuclear cells in vitro." Int Immunopharmacol 6(3): 390-395.
  • Zenuk, C., J. Healey, et al. (2003). "Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy." Can J Clin Pharmacol 10(4): 184-188.
  • Forsyth LM, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. Feb1999; 82(2):185-91).
  • Lenaz, G., R. Fato, et al. (1994). "An updating of the biochemical function of coenzyme Q in mitochondria." Mol Aspects Med 15 Suppl: s29-36.
  • Santaella ML, Font I, Disdier OM. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome.  P R Health Sci J. 2004 Jun;23(2):89-93.
  • Villalba, J. M. and P. Navas (2000). "Plasma membrane redox system in the control of stress-induced apoptosis." Antioxid Redox Signal 2(2): 213-230.
  • Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 2000 Apr;5(2):93-108.